Page Image

Triple-Negative Breast Cancer

Interpreting ASCENT-04 Findings With Dr. Sarah Tolaney
Sacituzumab + pembrolizumab improved PFS vs chemo in PD-L1+ TNBC in ASCENT-04, with no new safety signals.
Advertisement
Advertisement